View all cases
UPC CFI 191/2025
Mar 3, 2025·EP2279254: NOVEL LIPID FORMULATIONS FOR NUCLEIC ACID DELIVERY
- Case details
- StatusInterim PhaseActionInfringementCategoryMain Infringement Action
- Parties
- Division
- The Hague LD
- Technology
- Biotech · mRNA · Biotechnology
- Language
- English
Decisions
- 2025-05-23Preliminary objection
Procedural order from The Hague Local Division dated 23 May 2025 ruling on a preliminary objection raised by Moderna defendants. The court dismissed Moderna's jurisdictional objections concerning Moderna Spain, Moderna Poland, and Moderna Norway, finding that the UPC has international jurisdiction under Art. 8(1) Brussels I Recast (commercial relationship within the same group) and that the LD The Hague has local competence under Art. 33(1)(b) UPCA because Moderna Netherlands B.V. is domiciled in the Netherlands. An opt-out validity issue was also addressed. The decision allows the infringement proceedings to proceed on the merits.
Legal issues:International jurisdiction under Art. 7(2) and 8(1) Brussels I RecastLocal competence of LD The Hague under Art. 33(1)(b) UPCACommercial relationship among group defendantsValidity of opt-out
Documents
| Document title | Date | Public |
|---|---|---|
| Receipt | 2026-03-04 | Not public |
| Cover sheet | 2026-03-04 | Not public |
| Application document Claimant | 2026-03-04 | Not public |
| Receipt | 2026-02-25 | Not public |
| Cover sheet | 2026-02-25 | Not public |
| Receipt | 2026-02-25 | Not public |
| Cover sheet | 2026-02-25 | Not public |
| Document | 2026-02-25 | Not public |
| Further pleadings | 2026-02-25 | Not public |
| Exhibit Defendant | 2026-02-25 | Not public |
| action.communication.general | 2026-02-02 | Not public |
| Receipt | 2026-01-26 | Not public |
| Cover sheet | 2026-01-26 | Not public |
| Exhibit document Claimant | 2026-01-26 | Not public |
| Application document Claimant | 2026-01-26 | Not public |
| Receipt | 2026-01-26 | Not public |
| Cover sheet | 2026-01-26 | Not public |
| Exhibit document Defendant | 2026-01-26 | Not public |
| Exhibit document Defendant | 2026-01-26 | Not public |
| Further pleadings | 2026-01-26 | Not public |
| action.communication.general | 2026-01-26 | Not public |
| action.phaseChange.interimPhaseOpen | 2026-01-14 | Not public |
| action.phaseChange.writtenPhaseClose | 2026-01-14 | Not public |
| Cover sheet | 2025-11-25 | Not public |
| Further pleadings | 2025-11-25 | Not public |
| Exhibit document Defendant | 2025-11-25 | Not public |
| Receipt | 2025-11-25 | Not public |
| Cover sheet | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Exhibit document Defendant | 2025-11-24 | Not public |
| Statement of rejoinder | 2025-11-24 | Not public |
| Receipt | 2025-11-24 | Not public |
| Cover sheet | 2025-10-27 | Not public |
| Other document | 2025-10-27 | Not public |
| Receipt | 2025-10-27 | Not public |
| action.communication.general | 2025-10-23 | Not public |
| Cover sheet | 2025-10-17 | Not public |
| Application | 2025-10-17 | Not public |
| Other document | 2025-10-17 | Not public |
| Receipt | 2025-10-17 | Not public |
| Cover sheet | 2025-10-03 | Not public |
| Application | 2025-10-03 | Not public |
| Exhibit | 2025-10-03 | Not public |
| Exhibit | 2025-10-03 | Not public |
| Exhibit | 2025-10-03 | Not public |
| Receipt | 2025-10-03 | Not public |
| Cover sheet | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Exhibit | 2025-09-24 | Not public |
| Statement of reply | 2025-09-24 | Not public |
| Receipt | 2025-09-24 | Not public |
| Rejoinder on request to produce evidence | 2025-09-14 | Not public |
| Outcome of the Order | 2025-09-12 | Not public |
| uploaded for technical reasons only to close workflow | 2025-09-12 | Public |
| opportunity to comment | 2025-09-12 | Not public |
| 20250826 UPC Genevant Arbutus Reply R 190 Request signed | 2025-09-12 | Not public |
| Receipt | 2025-09-02 | Not public |
| Moderna R.9 RoP in response to R.190 RoP Application | 2025-09-02 | Not public |
| Receipt | 2025-08-28 | Not public |
| 25-08-27_-_EP_254_-__Further_comment_on__request_to_produce_evidence_-_Moderna_vs_Genevant | 2025-08-27 | Not public |
| Reply re R190 Request | 2025-08-26 | Not public |
| Exhibit G126 | 2025-08-26 | Not public |
| Panel-Appointment | 2025-08-18 | Not public |
| opportunity to comment | 2025-08-18 | Not public |
| R.37.2 order | 2025-08-15 | Public |
| Exhibit FS18 - DI 457 Letter May 2025 | 2025-08-14 | Not public |
| Exhibit FS17 - Protective Order | 2025-08-14 | Not public |
| Response to request to produce evidence (Rule 190 RoP) | 2025-08-14 | Not public |
| Joint statement regarding bifurcation | 2025-08-13 | Not public |
| Joint statement regarding bifurcation | 2025-08-13 | Not public |
| Statement regarding security pursuant to R.158 RoP | 2025-08-11 | Not public |
| Response to deadline extension request | 2025-08-08 | Not public |
| Response to deadline extension request | 2025-08-08 | Not public |
| Response to deadline extension request | 2025-08-08 | Not public |
| R.37.2 | 2025-08-06 | Not public |
| Hearing-Dates | 2025-08-06 | Not public |
| R.28 | 2025-08-06 | Public |
| Hearing-Dates | 2025-08-06 | Not public |
| REDACTED 20250804 Final order re R.262A applications | 2025-08-05 | Not public |
| opportunity to comment | 2025-08-04 | Not public |
| opportunity to comment | 2025-08-04 | Not public |
| opportunity to comment | 2025-08-04 | Not public |
| Outcome of the Order | 2025-08-04 | Not public |
| R.262A order | 2025-08-04 | Not public |
| R.262A order | 2025-08-04 | Public |
| R.262A order | 2025-08-04 | Public |
| Receipt | 2025-08-01 | Not public |
| Receipt | 2025-08-01 | Not public |
| Request for extension of deadlines | 2025-08-01 | Not public |
| Exhibit G125 | 2025-08-01 | Not public |
| Application for an Order to produce evidence | 2025-08-01 | Not public |
| Exhibit G124 | 2025-08-01 | Not public |
| Exhibit G123 | 2025-08-01 | Not public |
| R.262A Reply | 2025-07-28 | Not public |
| Exhibit G122 | 2025-07-28 | Not public |
| Receipt | 2025-07-25 | Not public |
| R.262A Reply | 2025-07-24 | Not public |
| Exhibit G122 | 2025-07-24 | Not public |
| Reference to response of Genevant | 2025-07-23 | Not public |
| R.262.2 Application | 2025-07-23 | Not public |
| CONFIDENTIAL Response to Security | 2025-07-23 | Not public |
| Exhibit G119 | 2025-07-23 | Not public |
| CONFIDENTIAL Response to Security | 2025-07-23 | Not public |
| Exhibit G121 - CONFIDENTIAL | 2025-07-23 | Not public |
| Exhibit G121 - CONFIDENTIAL | 2025-07-23 | Not public |
| Exhibit G120 | 2025-07-23 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Acknowledgement-of-lodging | 2025-07-11 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-07-11 | Not public |
| Annex 5 to Exhibit FBD-T 4 | 2025-07-10 | Not public |
| Exhibit FBD-T 19 | 2025-07-10 | Not public |
| Exhibit FBD-T 05 | 2025-07-10 | Not public |
| Exhibit FBD-T 17 | 2025-07-10 | Not public |
| Annex 3 to Exhibit FBD-T 4 | 2025-07-10 | Not public |
| Exhibit FBD-T 09a - CONFIDENTIAL | 2025-07-10 | Not public |
| Annex 7 to Exhibit FBD-T 4 | 2025-07-10 | Not public |
| Exhibit FBD-T 15 | 2025-07-10 | Not public |
| Exhibit FBD 12 -CONFIDENTIAL | 2025-07-10 | Not public |
| 2025-07-08_-_EP254_-_Moderna_vs_Genevant_-_Statement_of_Defence_-_ACT_10280_2025_-_CCR_32137_2025 - V2 | 2025-07-10 | Not public |
| Exhibit FBD 14 | 2025-07-10 | Not public |
| Annex 2 to Exhibit FBD-T 4 | 2025-07-10 | Not public |
| Set of Exhibits FBD 10 - Part 3 of 5 | 2025-07-10 | Not public |
| Exhibit FBD-T 01 | 2025-07-10 | Not public |
| Exhibit FBD 15 | 2025-07-10 | Not public |
| Exhibit FBD-T 03 | 2025-07-10 | Not public |
| Set of Exhibits FBD-T 09 - CONFIDENTIAL | 2025-07-10 | Not public |
| Exhibit FBD 16 | 2025-07-10 | Not public |
| Set of Exhibits FBD 10 - Part 5 of 5 | 2025-07-10 | Not public |
| Exhibit FBD 08 | 2025-07-10 | Not public |
| Annex 6 to Exhibit FBD-T 4 | 2025-07-10 | Not public |
| Exhibit FBD 13 | 2025-07-10 | Not public |
| Exhibit FBD-T 12 | 2025-07-10 | Not public |
| Exhibit FBD-T 10 | 2025-07-10 | Not public |
| Exhibit FBD-T 08 | 2025-07-10 | Not public |
| Exhibit FBD-T 13 | 2025-07-10 | Not public |
| Exhibit FBD-T 03a | 2025-07-10 | Not public |
| Exhibit FBD-T 07 | 2025-07-10 | Not public |
| Exhibit FBD 07 | 2025-07-10 | Not public |
| Annex 1 to Exhibit FBD-T 4 | 2025-07-10 | Not public |
| Set of Exhibits FBD 10 - Part 1 of 5 | 2025-07-10 | Not public |
| Set of Exhibits FBD 10 - Part 4 of 5 | 2025-07-10 | Not public |
| Exhibit FBD-T 14 | 2025-07-10 | Not public |
| Exhibit FBD-T 18 | 2025-07-10 | Not public |
| Exhibit FBD 11a | 2025-07-10 | Not public |
| Exhibit FBD-T 04 | 2025-07-10 | Not public |
| Exhibit FBD-T 02 | 2025-07-10 | Not public |
| Set of Exhibits FBD 10 - Part 2 of 5 | 2025-07-10 | Not public |
| Exhibit FBD-T 11 | 2025-07-10 | Not public |
| Exhibit FBD-T 16 | 2025-07-10 | Not public |
| Exhibit FBD-T 06 | 2025-07-10 | Not public |
| Exhibit FBD 06 | 2025-07-10 | Not public |
| Annex 4 to Exhibit FBD-T 4 | 2025-07-10 | Not public |
| Exhibit FBD 09 | 2025-07-10 | Not public |
| Set of Exhibits FBD 11 | 2025-07-10 | Not public |
| opportunity to comment | 2025-07-10 | Not public |
| Formal-checks_Request-for-correction | 2025-07-10 | Not public |
| opportunity to comment | 2025-07-09 | Not public |
| Receipt | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| 2025-07-08_-_UPC1_EP254_Reference_to_statement_of_defence_for_other_defendants(307430487.1) | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| Exhibit FBD 15 | 2025-07-09 | Not public |
| 25-07-08_-_UPC2_EP254_UPC_DRAFT_-_Request_security_pursuant_to_R158_No_32591_2025 | 2025-07-09 | Not public |
| Exhibit FBD 16 | 2025-07-09 | Not public |
| 25-07-08_-_UPC2_EP254_UPC_DRAFT_-_Confidentiality_request | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| Acknowledgement-of-lodging | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| EP 254 - Moderna Reference to Statement of Defence and Counterclaim for Revocation | 2025-07-09 | Not public |
| Exhibit FBD-T 11 | 2025-07-09 | Not public |
| Set of Exhibits FBD 10 - Part 5 of 5 | 2025-07-09 | Not public |
| Exhibit FBD 14 | 2025-07-09 | Not public |
| Exhibit FBD-T 17 | 2025-07-09 | Not public |
| Set of Exhibits FBD 10 - Part 1 of 5 | 2025-07-09 | Not public |
| Exhibit FBD-T 10 | 2025-07-09 | Not public |
| Exhibit FBD 12 -CONFIDENTIAL | 2025-07-09 | Not public |
| Set of Exhibits FBD-T 09 - CONFIDENTIAL | 2025-07-09 | Not public |
| Annex 1 to Exhibit FBD-T 4 | 2025-07-09 | Not public |
| Exhibit FBD 13 | 2025-07-09 | Not public |
| Exhibit FBD-T 08 | 2025-07-09 | Not public |
| Exhibit FBD-T 16 | 2025-07-09 | Not public |
| Exhibit FBD 08 | 2025-07-09 | Not public |
| Annex 4 to Exhibit FBD-T 4 | 2025-07-09 | Not public |
| 2025-07-08_-_EP254_-_Moderna_vs_Genevant_-_Statement_of_Defence_-_ACT_10280_2025_-_CCR_32137_2025 | 2025-07-09 | Not public |
| Exhibit FBD 09 | 2025-07-09 | Not public |
| Exhibit FBD-T 13 | 2025-07-09 | Not public |
| Exhibit FBD-T 09a - CONFIDENTIAL | 2025-07-09 | Not public |
| Exhibit FBD-T 14 | 2025-07-09 | Not public |
| Annex 2 to Exhibit FBD-T 4 | 2025-07-09 | Not public |
| Annex 6 to Exhibit FBD-T 4 | 2025-07-09 | Not public |
| Exhibit FBD-T 02 | 2025-07-09 | Not public |
| Exhibit FBD-T 09a - CONFIDENTIAL | 2025-07-09 | Not public |
| Exhibit FBD 07 | 2025-07-09 | Not public |
| Exhibit FBD-T 19 | 2025-07-09 | Not public |
| Exhibit FBD-T 06 | 2025-07-09 | Not public |
| Set of Exhibits FBD 10 - Part 3 of 5 | 2025-07-09 | Not public |
| Exhibit FBD-T 18 | 2025-07-09 | Not public |
| Exhibit FBD 12 -CONFIDENTIAL | 2025-07-09 | Not public |
| Exhibit FBD-T 15 | 2025-07-09 | Not public |
| Exhibit FBD-T 03a | 2025-07-09 | Not public |
| Exhibit FBD 06 | 2025-07-09 | Not public |
| Set of Exhibits FBD-T 09 - CONFIDENTIAL | 2025-07-09 | Not public |
| Annex 3 to Exhibit FBD-T 4 | 2025-07-09 | Not public |
| Annex 5 to Exhibit FBD-T 4 | 2025-07-09 | Not public |
| Exhibit FBD-T 03 | 2025-07-09 | Not public |
| Exhibit FBD 15 | 2025-07-09 | Not public |
| Exhibit FBD 11a | 2025-07-09 | Not public |
| Set of Exhibits FBD 11 | 2025-07-09 | Not public |
| 2025-07-08_-_EP254_-_Moderna_vs_Genevant_-_Statement_of_Defence_-_ACT_10280_2025_-_CCR_32137_2025 | 2025-07-09 | Not public |
| Exhibit FBD 16 | 2025-07-09 | Not public |
| Annex 7 to Exhibit FBD-T 4 | 2025-07-09 | Not public |
| Set of Exhibits FBD 10 - Part 2 of 5 | 2025-07-09 | Not public |
| Exhibit FBD-T 07 | 2025-07-09 | Not public |
| Exhibit FBD-T 12 | 2025-07-09 | Not public |
| Exhibit FBD-T 05 | 2025-07-09 | Not public |
| Exhibit FBD-T 01 | 2025-07-09 | Not public |
| Exhibit FBD-T 04 | 2025-07-09 | Not public |
| Set of Exhibits FBD 10 - Part 4 of 5 | 2025-07-09 | Not public |
| Response to request for review | 2025-06-19 | Not public |
| Response to request for review | 2025-06-19 | Not public |
| Outcome of the Order | 2025-06-12 | Not public |
| opportunity to comment | 2025-06-12 | Public |
| Acknowledgement-of-lodging | 2025-06-11 | Not public |
| Exhibit FBD 5 | 2025-06-06 | Not public |
| 25-06-06_-_EP_254_and_EP_767_-_Request_for_Panel_Review_-_Moderna_vs_Genevant_-_App_No_27016_2025.pdf | 2025-06-06 | Not public |
| Headnote-and-Keywords | 2025-06-04 | Not public |
| Outcome of the Order | 2025-06-04 | Not public |
| rectification | 2025-06-04 | Public |
| Headnote-and-Keywords | 2025-06-04 | Not public |
| Headnote-and-Keywords | 2025-06-04 | Not public |
| Response to request for rectification | 2025-06-02 | Not public |
| Response to request for rectification | 2025-06-02 | Not public |
| opportunity to comment | 2025-05-28 | Not public |
| Receipt | 2025-05-27 | Not public |
| 25-05-27_-_Request_for_Rectification_-_Moderna_vs_Genevant_-_CFI_191_2025_and_CFI_192_2025 | 2025-05-27 | Not public |
| Preliminary_Objection_DecisionOutcome | 2025-05-23 | Not public |
| R.19 order | 2025-05-23 | Public |
| Preliminary_Objection_DecisionOutcome | 2025-05-23 | Not public |
| R.19 order | 2025-05-23 | Public |
| Comment-On-Preliminary-Objection | 2025-05-07 | Not public |
| Exhibit G117 - Certificate amalgamation | 2025-05-07 | Not public |
| Exhibit G115 - opt-out | 2025-05-07 | Not public |
| Comment on Preliminary objection | 2025-05-07 | Not public |
| Exhibit G118 - Notice 2025 European tender | 2025-05-07 | Not public |
| Exhibit G116 - Opt-out confirmation | 2025-05-07 | Not public |
| Comment-On-Preliminary-Objection | 2025-05-07 | Not public |
| Exhibit G115 - opt-out | 2025-05-07 | Not public |
| Exhibit G117 - Certificate amalgamation | 2025-05-07 | Not public |
| Comment on Preliminary objection | 2025-05-07 | Not public |
| Exhibit G116 - Opt-out confirmation | 2025-05-07 | Not public |
| Exhibit G118 - Notice 2025 European tender | 2025-05-07 | Not public |
| Notification Of Service | 2025-05-06 | Not public |
| 2025_05_05 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Norway AS | 2025-05-06 | Not public |
| Acknowledgement of access to case | 2025-05-05 | Not public |
| Acknowledgement of access to case | 2025-05-05 | Not public |
| Acknowledgement of access to case | 2025-05-05 | Not public |
| Acknowledgement of access to case | 2025-05-05 | Not public |
| Notification Of Service | 2025-05-01 | Not public |
| 2025_03_24 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Switzerland GmbH | 2025-05-01 | Not public |
| Preliminary-Objection | 2025-04-25 | Not public |
| Notification Of Service | 2025-04-25 | Not public |
| 2025-23-05 ACT_10280-2025 UPC_CFI_191-2025 Confirmation of Service | 2025-04-25 | Not public |
| Exhibit FBD 2 - National registers | 2025-04-25 | Not public |
| 25-04-24 - EP 254 - Preliminary objection - Moderna vs Genevant - signed | 2025-04-25 | Not public |
| Exhibit FBD 3 - Dutch Patent register | 2025-04-25 | Not public |
| Exhibit FBD 4 - Moderna PL | 2025-04-25 | Not public |
| Preliminary-Objection | 2025-04-23 | Not public |
| Preliminary objection Moderna UK - Moderna vs Genevant (EP 254) signed | 2025-04-22 | Not public |
| Exhibit FBD 3 - Dutch Patent register | 2025-04-22 | Not public |
| Exhibit FBD 2 - National registers | 2025-04-22 | Not public |
| Notification Of Service | 2025-04-22 | Not public |
| 2025_04_21 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Inc. | 2025-04-22 | Not public |
| Headnote-and-Keywords | 2025-04-17 | Not public |
| this order is issued in this workflow for technical reasons only | 2025-04-17 | Public |
| Outcome of the Order | 2025-04-17 | Not public |
| this order is issued in this workflow for technical reasons only | 2025-04-17 | Public |
| Receipt | 2025-04-17 | Not public |
| Outcome of the Order | 2025-04-17 | Not public |
| setting deadline for SoD | 2025-04-17 | Public |
| Template-Order | 2025-04-17 | Not public |
| Response to letter Brinkhof d.d. 17 April 2025 | 2025-04-17 | Not public |
| Receipt | 2025-04-17 | Not public |
| R9 Request re service Moderna Inc and ModernaTX Inc | 2025-04-17 | Not public |
| Exhibit G114 - Letter re representation MLL of Moderna Inc ModernaTX Inc | 2025-04-17 | Not public |
| Notification Of Service | 2025-04-15 | Not public |
| 2025_04_07 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Sweden AB | 2025-04-15 | Not public |
| Receipt | 2025-04-15 | Not public |
| 25-04-15 - EP 254 - Response re deadline extension | 2025-04-15 | Not public |
| Receipt | 2025-04-14 | Not public |
| R 9 aplication reply to R 9 request | 2025-04-14 | Not public |
| opportunity to comment | 2025-04-10 | Not public |
| Template-Order | 2025-04-10 | Not public |
| opportunity to comment | 2025-04-09 | Not public |
| Receipt | 2025-04-09 | Not public |
| 25-04-09 - EP 254 - Request for deadline extension - Moderna vs Genevant_Arbutus - CFI 191_2025 - ACT 10280_2025 | 2025-04-09 | Not public |
| Exhibit FBD 1 | 2025-04-09 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_21 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Biotech UK Limited | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_24 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna France SASU | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_21 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Germany GmbH | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_27 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Netherlands B.V. | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_26 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Denmark ApS | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_24 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Biotech Spain SL | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_27 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Italy S.R.L. | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_27 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Portugal Unipessoal LDA | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_25 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Poland SP. Z.O.O. | 2025-04-01 | Not public |
| Notification Of Service | 2025-04-01 | Not public |
| 2025_03_21 ACT_10280_2025 UPC_CFI_191_2025 Confirmation of Service Moderna Belgium S.R.L. | 2025-04-01 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-31 | Not public |
| Acknowledgement of access to case | 2025-03-28 | Not public |
| Acknowledgement of access to case | 2025-03-24 | Not public |
| Panel-Appointment | 2025-03-17 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Letter-for-Service | 2025-03-13 | Not public |
| Document from EPO | 2025-03-11 | Not public |
| Panel-Appointment | 2025-03-06 | Not public |
| EPO-Request-for-case-pending | 2025-03-06 | Not public |
| Receipt | 2025-03-06 | Not public |
| Formal-checks_Notification-of-positive-outcome | 2025-03-06 | Not public |
| Exhibit G075 - Modernacovid19global website | 2025-03-05 | Not public |
| Exhibit M.01 - Samaridou 2020 | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G084 - Moderna NL Annual Report 2023 | 2025-03-05 | Not public |
| Exhibit G087 - Moderna NL PL tender notice PL | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G077.5 - APA EC Moderna CH 2020 p 36-44 | 2025-03-05 | Not public |
| Exhibit G047 - MR redlined | 2025-03-05 | Not public |
| Exhibit G015 - Moderna NIH preprint 2020 | 2025-03-05 | Not public |
| Exhibit G082 - EC Draft framework contract | 2025-03-05 | Not public |
| Exhibit G008 - Zimmerman 2006 | 2025-03-05 | Not public |
| Exhibit G003 - Confirmatory declaration Genevant-Arbutus | 2025-03-05 | Not public |
| Exhibit G102 - Moderna Norway trade register | 2025-03-05 | Not public |
| Exhibit G098 - Moderna Italy trade register | 2025-03-05 | Not public |
| Exhibit G063 - Moderna press release 23 August 2024 | 2025-03-05 | Not public |
| Raw Data - LC-CAD_Sample C2 | 2025-03-05 | Not public |
| Exhibit G017 - US8058069 | 2025-03-05 | Not public |
| Exhibit G045 - petitioners hearing slides slide 27 | 2025-03-05 | Not public |
| Exhibit G092 - Moderna Netherlands Madrid | 2025-03-05 | Not public |
| Exhibit G077.7 - APA EC Moderna CH 2020 p 54-60 | 2025-03-05 | Not public |
| Exhibit G112 - Moderna 2023 annual report p. 119 | 2025-03-05 | Not public |
| Exhibit G032 - US 20080020058 (Chen) | 2025-03-05 | Not public |
| Exhibit G009 - Semple 2010 | 2025-03-05 | Not public |
| Exhibit G062 - mRESVIA SmPC | 2025-03-05 | Not public |
| Exhibit G096 - Moderna Germany trade register | 2025-03-05 | Not public |
| Exhibit G093 - Moderna Poland trade register | 2025-03-05 | Not public |
| Exhibit G006 - Arbutus Biopharma Corporation trade register excerpt | 2025-03-05 | Not public |
| Exhibit G089 - Spikevax Lauer Taxe Germany | 2025-03-05 | Not public |
| Exhibit G023 - Genevant press release 2022 | 2025-03-05 | Not public |
| Exhibit G076 - Moderna Switzerland trade register | 2025-03-05 | Not public |
| Exhibit G058 - WO2021222304A1 | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G105 - Moderna CH service agreement TR | 2025-03-05 | Not public |
| Exhibit G059 - WO2022197624A1 | 2025-03-05 | Not public |
| Exhibit G077.1 - APA EC Moderna CH 2020 p 1-8 | 2025-03-05 | Not public |
| Exhibit G012 - Corbett Nature Review 2020 | 2025-03-05 | Not public |
| Exhibit G087 - Moderna NL PL tender notice PL | 2025-03-05 | Not public |
| Exhibit G093 - Moderna Poland trade register | 2025-03-05 | Not public |
| Exhibit G035 - T 0505_20 | 2025-03-05 | Not public |
| Exhibit G034 - Information about the result of oral proceedings of 10 October 2019 | 2025-03-05 | Not public |
| Exhibit G010 - Suzuki 2023 | 2025-03-05 | Not public |
| Exhibit G097 - Moderna France trade register | 2025-03-05 | Not public |
| Exhibit G055 - Bahl 2017 | 2025-03-05 | Not public |
| Exhibit G097 - Moderna France trade register | 2025-03-05 | Not public |
| Exhibit G078 - EX - PA EC Moderna CH 2021 | 2025-03-05 | Not public |
| Exhibit G083 - Moderna NL Trade Register | 2025-03-05 | Not public |
| Exhibit A - CV Thomas Lassak | 2025-03-05 | Not public |
| Exhibit G056 - Richner 2017 | 2025-03-05 | Not public |
| Exhibit G039 - Main Request | 2025-03-05 | Not public |
| Exhibit G028 - Amendments received before examination 30 December 2010 | 2025-03-05 | Not public |
| Exhibit G091 - Moderna ES trade register | 2025-03-05 | Not public |
| Exhibit G026 - US20080045228P - priority document | 2025-03-05 | Not public |
| Exhibit G065 - Transcript Moderna Vaccines Day 14 April 2021 selection | 2025-03-05 | Not public |
| Exhibit G046 - Mitchell Report | 2025-03-05 | Not public |
| Exhibit G016 - Moore Harvard Business School 2020 | 2025-03-05 | Not public |
| Exhibit G092 - Moderna Netherlands Madrid | 2025-03-05 | Not public |
| Exhibit G113 - Moderna Inc 2024 annual report selection | 2025-03-05 | Not public |
| Exhibit G094 - Moderna UK trade register | 2025-03-05 | Not public |
| Exhibit G036 - OD Decision 2024 | 2025-03-05 | Not public |
| Exhibit G103 - Moderna Portugal trade register | 2025-03-05 | Not public |
| Exhibit M.03 - Semple 2010 | 2025-03-05 | Not public |
| Exhibit G067 - Modernas RD Day Transcript 17 September 2020 selection | 2025-03-05 | Not public |
| Exhibit G049 - EPO AR1 to AR13 | 2025-03-05 | Not public |
| Exhibit G096 - Moderna Germany trade register | 2025-03-05 | Not public |
| Raw data - LC-CAD_Sample C3 | 2025-03-05 | Not public |
| Exhibit G077.6 - APA EC Moderna CH 2020 p 45-53 | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G101 - Moderna Sweden trade register | 2025-03-05 | Not public |
| Exhibit G014 - Cross CEN News 2021 | 2025-03-05 | Not public |
| Exhibit C - Qualification Report | 2025-03-05 | Not public |
| Exhibit G050 - EMA assessment report Spikevax | 2025-03-05 | Not public |
| Exhibit G066 - Modernas RD Day Presentation 17 September 2020 slide 92 | 2025-03-05 | Not public |
| Exhibit G004 - proof of payment court fees | 2025-03-05 | Not public |
| Exhibit G044 - Anchordoquy deposition transcript p. 70-73 | 2025-03-05 | Not public |
| Exhibit G079 - EC press release 2025 tender | 2025-03-05 | Not public |
| Exhibit G081 - Moderna Inc. press release Chantal-Friebertshauser 2022 | 2025-03-05 | Not public |
| Exhibit G057 - WO2021159130A2 | 2025-03-05 | Not public |
| Exhibit G109 - Moderna ROVI 2022 press release | 2025-03-05 | Not public |
| Exhibit G091 - Moderna ES trade register | 2025-03-05 | Not public |
| Exhibit G072 - ModernaTX trade register excerpt | 2025-03-05 | Not public |
| Exhibit G029 - Extended European Search Report 12 October 2012 | 2025-03-05 | Not public |
| Exhibit G073 - Domain registrations Moderna | 2025-03-05 | Not public |
| Exhibit G085 - Moderna NL Hungary contract 2023 HUN | 2025-03-05 | Not public |
| Exhibit G020 - IPR Final Written Decision (435) | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G080 - Moderna press release 2025 tender | 2025-03-05 | Not public |
| Exhibit G077.3 - APA EC Moderna CH 2020 p 18-26 | 2025-03-05 | Not public |
| Exhibit G043 - D44 - Declaration Heyes | 2025-03-05 | Not public |
| Exhibit G053 - John 2018 | 2025-03-05 | Not public |
| Raw Data - LC-CAD_Sample C1 | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G101 - Moderna Sweden trade register | 2025-03-05 | Not public |
| Exhibit G107 - Lonza press release 2021 | 2025-03-05 | Not public |
| Exhibit G021 - Federal Circuit Opinion (069) | 2025-03-05 | Not public |
| Exhibit G048 - AR13 redlined | 2025-03-05 | Not public |
| Exhibit G077.2 - APA EC Moderna CH 2020 p 9-17 | 2025-03-05 | Not public |
| Exhibit G025 - WO2009127060A1 original application | 2025-03-05 | Not public |
| Exhibit G077.4 - APA EC Moderna CH 2020 p 27-35 | 2025-03-05 | Not public |
| Exhibit G100 - Moderna Denmark trade register | 2025-03-05 | Not public |
| Exhibit G100 - Moderna Denmark trade register | 2025-03-05 | Not public |
| Exhibit G007 - Spikevax SmPC | 2025-03-05 | Not public |
| Exhibit G104 - Moderna Lonza press release 2020 | 2025-03-05 | Not public |
| Exhibit G074 - Modernatx website | 2025-03-05 | Not public |
| Exhibit G111 - Moderna RECIPHARM 2021 press release | 2025-03-05 | Not public |
| Exhibit G068 - Coriolis Report | 2025-03-05 | Not public |
| Exhibit G088 - Moderna NL tender notice Poland PL | 2025-03-05 | Not public |
| Exhibit G030 - Amended claims filed after receipt of search report 7 May 2013 | 2025-03-05 | Not public |
| Exhibit M.04 - United States Pharmacopeia | 2025-03-05 | Not public |
| Exhibit G027 - withdrawal of the op-out | 2025-03-05 | Not public |
| Exhibit G099 - Moderna Belgium trade register | 2025-03-05 | Not public |
| Exhibit G019 - IPR Final Written Decision (069) | 2025-03-05 | Not public |
| Exhibit G102 - Moderna Norway trade register | 2025-03-05 | Not public |
| Exhibit G086 - Moderna NL Hungary contract 2024 | 2025-03-05 | Not public |
| Exhibit G077.8 - APA EC Moderna CH 2020 p 61- | 2025-03-05 | Not public |
| Exhibit G061 Mitchell report table of content | 2025-03-05 | Not public |
| Exhibit B - CV Katharina Edenharter | 2025-03-05 | Not public |
| Exhibit G002 - patent register excerpts | 2025-03-05 | Not public |
| Exhibit G001 - EP2279254B1 | 2025-03-05 | Not public |
| Exhibit G106 - Moderna press release Lonza NL 2021 | 2025-03-05 | Not public |
| Exhibit G013 - Regalado MIT Technology 2020 | 2025-03-05 | Not public |
| Exhibit G005 - Genevant Sciences trade register | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G070 - Moderna Inc 2024 annual report exhibit 21 1 | 2025-03-05 | Not public |
| Exhibit G022 - Federal Circuit Opinion (435) | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G038 - US 2006_0240554 (D25) | 2025-03-05 | Not public |
| Exhibit G031 - Amended claim with annotations 13 September 2013 | 2025-03-05 | Not public |
| Exhibit G064 - EMA assesment report mRESVIA | 2025-03-05 | Not public |
| Exhibit G042 - D43 - Declaration Heyes | 2025-03-05 | Not public |
| Exhibit G051 - Hassett 2019 | 2025-03-05 | Not public |
| Exhibit G069 - Moderna Inc trade register excerpt | 2025-03-05 | Not public |
| Exhibit G024 - Samaridou 2020 | 2025-03-05 | Not public |
| Statement of Claim EP254 da | 2025-03-05 | Not public |
| Exhibit G041 - Modernas GoA of 22 November 2024 | 2025-03-05 | Not public |
| Exhibit G018 - US9364435 | 2025-03-05 | Not public |
| Exhibit G108 - Moderna ROVI 2020 press release | 2025-03-05 | Not public |
| Exhibit G060 Coriolis report table of content | 2025-03-05 | Not public |
| Exhibit G040 - Arbutuss GoA of 25 November 2024 | 2025-03-05 | Not public |
| Exhibit G071 - Moderna Inc 2022 press release | 2025-03-05 | Not public |
| Exhibit G088 - Moderna NL tender notice Poland PL | 2025-03-05 | Not public |
| Raw data - UV | 2025-03-05 | Not public |
| Exhibit G011 - Shaun Ryan (Moderna) Declaration | 2025-03-05 | Not public |
| Exhibit G090 - mRESVIA Lauer Taxe Germany | 2025-03-05 | Not public |
| Exhibit G037 - Auxiliary request 13 | 2025-03-05 | Not public |
| Exhibit G110 - Moderna RECIPHARM 2020 press release | 2025-03-05 | Not public |
| Raw data - DLS | 2025-03-05 | Not public |
| Statement of Claim EP 254_signed | 2025-03-05 | Not public |
| Exhibit G083 - Moderna NL Trade Register | 2025-03-05 | Not public |
| Exhibit G052 - Peer review Corbett Nature | 2025-03-05 | Not public |
| Exhibit M.02 - Katalin Karikó, Keynote Lecture | 2025-03-05 | Not public |
| Exhibit G103 - Moderna Portugal trade register | 2025-03-05 | Not public |
| Exhibit G095 - Moderna UK Annual report 2023 | 2025-03-05 | Not public |
| Exhibit G054 - Espeseth 2020 | 2025-03-05 | Not public |
| Exhibit G085 - Moderna NL Hungary contract 2023 HUN | 2025-03-05 | Not public |
| Exhibit G033 - OD Decision 2019 | 2025-03-05 | Not public |
| Formal-checks_Request-for-correction | 2025-03-04 | Not public |
| Acknowledgement-of-lodging | 2025-03-03 | Not public |
| Exhibit G111 - Moderna RECIPHARM 2021 press release | 2025-03-03 | Not public |
| Raw Data - LC-CAD_Sample C1 | 2025-03-03 | Not public |
| Exhibit G101 - Moderna Sweden trade register | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G040 - Arbutuss GoA of 25 November 2024 | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G010 - Suzuki 2023 | 2025-03-03 | Not public |
| Exhibit G090 - mRESVIA Lauer Taxe Germany | 2025-03-03 | Not public |
| Exhibit G077.1 - APA EC Moderna CH 2020 p 1-8 | 2025-03-03 | Not public |
| Exhibit G034 - Information about the result of oral proceedings of 10 October 2019 | 2025-03-03 | Not public |
| Raw Data - LC-CAD_Sample C2 | 2025-03-03 | Not public |
| Exhibit G077.4 - APA EC Moderna CH 2020 p 27-35 | 2025-03-03 | Not public |
| Exhibit G068 - Coriolis Report | 2025-03-03 | Not public |
| Exhibit G103 - Moderna Portugal trade register | 2025-03-03 | Not public |
| Exhibit G053 - John 2018 | 2025-03-03 | Not public |
| Exhibit G060 Coriolis report table of content | 2025-03-03 | Not public |
| Exhibit G024 - Samaridou 2020 | 2025-03-03 | Not public |
| Raw data - DLS | 2025-03-03 | Not public |
| Exhibit C - Qualification Report | 2025-03-03 | Not public |
| Exhibit G056 - Richner 2017 | 2025-03-03 | Not public |
| Exhibit G057 - WO2021159130A2 | 2025-03-03 | Not public |
| Exhibit G029 - Extended European Search Report 12 October 2012 | 2025-03-03 | Not public |
| Exhibit G002 - patent register excerpts | 2025-03-03 | Not public |
| Exhibit G093 - Moderna Poland trade register | 2025-03-03 | Not public |
| Exhibit G074 - Modernatx website | 2025-03-03 | Not public |
| Exhibit G092 - Moderna Netherlands Madrid | 2025-03-03 | Not public |
| Exhibit G054 - Espeseth 2020 | 2025-03-03 | Not public |
| Exhibit G077.5 - APA EC Moderna CH 2020 p 36-44 | 2025-03-03 | Not public |
| Exhibit G113 - Moderna Inc 2024 annual report selection | 2025-03-03 | Not public |
| Exhibit M.03 - Semple 2010 | 2025-03-03 | Not public |
| Exhibit G067 - Modernas RD Day Transcript 17 September 2020 selection | 2025-03-03 | Not public |
| Exhibit G071 - Moderna Inc 2022 press release | 2025-03-03 | Not public |
| Exhibit M.04 - United States Pharmacopeia | 2025-03-03 | Not public |
| Exhibit G088 - Moderna NL tender notice Poland PL | 2025-03-03 | Not public |
| Exhibit G110 - Moderna RECIPHARM 2020 press release | 2025-03-03 | Not public |
| Exhibit G026 - US20080045228P - priority document | 2025-03-03 | Not public |
| Exhibit G112 - Moderna 2023 annual report p. 119 | 2025-03-03 | Not public |
| Exhibit G049 - EPO AR1 to AR13 | 2025-03-03 | Not public |
| Exhibit G097 - Moderna France trade register | 2025-03-03 | Not public |
| Exhibit G080 - Moderna press release 2025 tender | 2025-03-03 | Not public |
| Exhibit G078 - EX - PA EC Moderna CH 2021 | 2025-03-03 | Not public |
| Exhibit G081 - Moderna Inc. press release Chantal-Friebertshauser 2022 | 2025-03-03 | Not public |
| Exhibit G087 - Moderna NL PL tender notice PL | 2025-03-03 | Not public |
| Exhibit G035 - T 0505_20 | 2025-03-03 | Not public |
| Exhibit G098 - Moderna Italy trade register | 2025-03-03 | Not public |
| Exhibit G009 - Semple 2010 | 2025-03-03 | Not public |
| Exhibit G011 - Shaun Ryan (Moderna) Declaration | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G082 - EC Draft framework contract | 2025-03-03 | Not public |
| Exhibit G042 - D43 - Declaration Heyes | 2025-03-03 | Not public |
| Exhibit G066 - Modernas RD Day Presentation 17 September 2020 slide 92 | 2025-03-03 | Not public |
| Exhibit G106 - Moderna press release Lonza NL 2021 | 2025-03-03 | Not public |
| Exhibit G036 - OD Decision 2024 | 2025-03-03 | Not public |
| Exhibit G109 - Moderna ROVI 2022 press release | 2025-03-03 | Not public |
| Exhibit G069 - Moderna Inc trade register excerpt | 2025-03-03 | Not public |
| Exhibit G077.2 - APA EC Moderna CH 2020 p 9-17 | 2025-03-03 | Not public |
| Exhibit G073 - Domain registrations Moderna | 2025-03-03 | Not public |
| Exhibit G079 - EC press release 2025 tender | 2025-03-03 | Not public |
| Exhibit G083 - Moderna NL Trade Register | 2025-03-03 | Not public |
| Exhibit G085 - Moderna NL Hungary contract 2023 HUN | 2025-03-03 | Not public |
| Exhibit G018 - US9364435 | 2025-03-03 | Not public |
| Exhibit G016 - Moore Harvard Business School 2020 | 2025-03-03 | Not public |
| Exhibit G028 - Amendments received before examination 30 December 2010 | 2025-03-03 | Not public |
| Exhibit G102 - Moderna Norway trade register | 2025-03-03 | Not public |
| Exhibit G037 - Auxiliary request 13 | 2025-03-03 | Not public |
| Exhibit G004 - proof of payment court fees | 2025-03-03 | Not public |
| Exhibit G087 - Moderna NL PL tender notice PL | 2025-03-03 | Not public |
| Exhibit G007 - Spikevax SmPC | 2025-03-03 | Not public |
| Exhibit G023 - Genevant press release 2022 | 2025-03-03 | Not public |
| Exhibit G089 - Spikevax Lauer Taxe Germany | 2025-03-03 | Not public |
| Exhibit G019 - IPR Final Written Decision (069) | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G050 - EMA assessment report Spikevax | 2025-03-03 | Not public |
| Exhibit G094 - Moderna UK trade register | 2025-03-03 | Not public |
| Exhibit G014 - Cross CEN News 2021 | 2025-03-03 | Not public |
| Exhibit G039 - Main Request | 2025-03-03 | Not public |
| Exhibit G084 - Moderna NL Annual Report 2023 | 2025-03-03 | Not public |
| Exhibit G077.6 - APA EC Moderna CH 2020 p 45-53 | 2025-03-03 | Not public |
| Exhibit G043 - D44 - Declaration Heyes | 2025-03-03 | Not public |
| Exhibit G104 - Moderna Lonza press release 2020 | 2025-03-03 | Not public |
| Exhibit G075 - Modernacovid19global website | 2025-03-03 | Not public |
| Exhibit M.02 - Katalin Karikó, Keynote Lecture | 2025-03-03 | Not public |
| Exhibit G012 - Corbett Nature Review 2020 | 2025-03-03 | Not public |
| Exhibit G077.8 - APA EC Moderna CH 2020 p 61- | 2025-03-03 | Not public |
| Exhibit G048 - AR13 redlined | 2025-03-03 | Not public |
| Raw data - UV | 2025-03-03 | Not public |
| Exhibit G100 - Moderna Denmark trade register | 2025-03-03 | Not public |
| Exhibit A - CV Thomas Lassak | 2025-03-03 | Not public |
| Exhibit G107 - Lonza press release 2021 | 2025-03-03 | Not public |
| Exhibit G085 - Moderna NL Hungary contract 2023 HUN | 2025-03-03 | Not public |
| Exhibit G088 - Moderna NL tender notice Poland PL | 2025-03-03 | Not public |
| Exhibit G077.3 - APA EC Moderna CH 2020 p 18-26 | 2025-03-03 | Not public |
| Exhibit G001 - EP2279254B1 | 2025-03-03 | Not public |
| Exhibit G063 - Moderna press release 23 August 2024 | 2025-03-03 | Not public |
| Exhibit G006 - Arbutus Biopharma Corporation trade register excerpt | 2025-03-03 | Not public |
| Exhibit G103 - Moderna Portugal trade register | 2025-03-03 | Not public |
| Exhibit G102 - Moderna Norway trade register | 2025-03-03 | Not public |
| Exhibit M.01 - Samaridou 2020 | 2025-03-03 | Not public |
| Exhibit G041 - Modernas GoA of 22 November 2024 | 2025-03-03 | Not public |
| Exhibit G059 - WO2022197624A1 | 2025-03-03 | Not public |
| Exhibit G027 - withdrawal of the op-out | 2025-03-03 | Not public |
| Exhibit G033 - OD Decision 2019 | 2025-03-03 | Not public |
| Exhibit G108 - Moderna ROVI 2020 press release | 2025-03-03 | Not public |
| Exhibit G064 - EMA assesment report mRESVIA | 2025-03-03 | Not public |
| Exhibit G105 - Moderna CH service agreement TR | 2025-03-03 | Not public |
| Exhibit G070 - Moderna Inc 2024 annual report exhibit 21 1 | 2025-03-03 | Not public |
| Exhibit G083 - Moderna NL Trade Register | 2025-03-03 | Not public |
| Exhibit G100 - Moderna Denmark trade register | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G065 - Transcript Moderna Vaccines Day 14 April 2021 selection | 2025-03-03 | Not public |
| Exhibit G051 - Hassett 2019 | 2025-03-03 | Not public |
| Exhibit G045 - petitioners hearing slides slide 27 | 2025-03-03 | Not public |
| Exhibit G096 - Moderna Germany trade register | 2025-03-03 | Not public |
| Exhibit G091 - Moderna ES trade register | 2025-03-03 | Not public |
| Exhibit G047 - MR redlined | 2025-03-03 | Not public |
| Exhibit G020 - IPR Final Written Decision (435) | 2025-03-03 | Not public |
| Exhibit G030 - Amended claims filed after receipt of search report 7 May 2013 | 2025-03-03 | Not public |
| Exhibit G058 - WO2021222304A1 | 2025-03-03 | Not public |
| Exhibit G025 - WO2009127060A1 original application | 2025-03-03 | Not public |
| Exhibit G046 - Mitchell Report | 2025-03-03 | Not public |
| Exhibit G095 - Moderna UK Annual report 2023 | 2025-03-03 | Not public |
| Exhibit G092 - Moderna Netherlands Madrid | 2025-03-03 | Not public |
| Exhibit B - CV Katharina Edenharter | 2025-03-03 | Not public |
| Exhibit G086 - Moderna NL Hungary contract 2024 | 2025-03-03 | Not public |
| Raw data - LC-CAD_Sample C3 | 2025-03-03 | Not public |
| Exhibit G021 - Federal Circuit Opinion (069) | 2025-03-03 | Not public |
| Exhibit G003 - Confirmatory declaration Genevant-Arbutus | 2025-03-03 | Not public |
| Exhibit G091 - Moderna ES trade register | 2025-03-03 | Not public |
| Exhibit G044 - Anchordoquy deposition transcript p. 70-73 | 2025-03-03 | Not public |
| Exhibit G093 - Moderna Poland trade register | 2025-03-03 | Not public |
| Exhibit G099 - Moderna Belgium trade register | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G032 - US 20080020058 (Chen) | 2025-03-03 | Not public |
| Exhibit G076 - Moderna Switzerland trade register | 2025-03-03 | Not public |
| Exhibit G038 - US 2006_0240554 (D25) | 2025-03-03 | Not public |
| Exhibit G008 - Zimmerman 2006 | 2025-03-03 | Not public |
| Exhibit G077.7 - APA EC Moderna CH 2020 p 54-60 | 2025-03-03 | Not public |
| Exhibit G013 - Regalado MIT Technology 2020 | 2025-03-03 | Not public |
| Exhibit G096 - Moderna Germany trade register | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G062 - mRESVIA SmPC | 2025-03-03 | Not public |
| 20250303 EP254 SoC DA | 2025-03-03 | Not public |
| Exhibit G061 Mitchell report table of content | 2025-03-03 | Not public |
| Exhibit G052 - Peer review Corbett Nature | 2025-03-03 | Not public |
| Exhibit G005 - Genevant Sciences trade register | 2025-03-03 | Not public |
| 20250303 Statement of Claim EP 254_signed | 2025-03-03 | Not public |
| Exhibit G097 - Moderna France trade register | 2025-03-03 | Not public |
| Exhibit G017 - US8058069 | 2025-03-03 | Not public |
| Exhibit G055 - Bahl 2017 | 2025-03-03 | Not public |
| Exhibit G072 - ModernaTX trade register excerpt | 2025-03-03 | Not public |
| Exhibit G022 - Federal Circuit Opinion (435) | 2025-03-03 | Not public |
| Exhibit G015 - Moderna NIH preprint 2020 | 2025-03-03 | Not public |
| Exhibit G101 - Moderna Sweden trade register | 2025-03-03 | Not public |
| Exhibit G031 - Amended claim with annotations 13 September 2013 | 2025-03-03 | Not public |